Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

February 3, 2012 |

On Tuesday night, PIPC Chairman Tony Coelho joined former HHS Secretary Tommy Thompson at the University of Charleston in West Virginia for a speaker series titled "Who Decides Patient Treatments" to discuss the future of health care in the United States.

| Read More
January 30, 2012 |

PCORI released a draft of their National Priorities for Research and Research Agenda for public comment. The PCORI Board, which is responsible for funding research, is asking for a 55 day public comment period to discuss and solicit feedback from patients, caregivers, professionals, and the general public on the research priorities.

In the draft, PCORI prioritized five broad research areas:

| Read More
October 18, 2011 |

When conducting Comparative Effectiveness Research it is crucial to understand the differences between the players involved in the process. In his remarks at the  2nd Annual Forum on Achieving Patient centeredness , Marc Boutin, executive vice president and COO at the National Health Council, discussed the important differences between the three major players in the process: the patient, the consumer, and the patient advocacy organization. He stated that many times when the patient is discussed they are not defined.

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

Patient Group Supports CER Language in Senate Health Care Reform Bill

WASHINGTON, DC – The Partnership to Improve Patient Care (PIPC) today applauded Senator Reid’s Patient Protection and Affordable Care Act for including strong patient-centered comparative effectiveness research (CER) language. The CER language is based on the approach taken by Senators Baucus and Conrad in their CER bill (S. 1213), which is supported by over 100 organizations across the country, representing patients, providers, people with disabilities, and minority health organizations.    

“Although we’re still reviewing the language, everything we’ve seen so far  indicates that the CER provisions in the Senate bill are focused on patient and provider needs and include many of the safeguards the people in our community have been looking for," PIPC chairman and epilepsy patient Tony Coelho said.  “The legislative process is never an easy one, but we’re glad that Senator Reid has kept the spirit of Senator Baucus’s comparative effectiveness research language intact.  Treatment decisions must always remain between a patient and his or her health care provider, and PIPC believes that everyone can benefit from a strong patient-centered approach to CER.  PIPC looks forward to continuing to work with lawmakers to ensure CER is about supporting patients and providers in making good health care choices, and not about dictating those choices to them through centralized coverage policies or mandatory ‘best practices.’”

Mr. Coelho continued, “The most important stakeholder in health care is the patient.  This bill provides a sound framework for independent, sustained, and objective research that is focused on the needs of patients. By creating an independent research institute – outside of the government – and including significant patient safeguards, the CER provisions will ensure that relevant, credible data is available to patients and their healthcare providers, and help ensure that information is used to inform treatment options, not limit them.”

The Patient Protection and Affordable Care Act includes a number of provisions to ensure that CER is used to benefit the needs of patients.  It would create an independent institute governed by patients, providers, government officials and other stakeholders and it further strengthens safeguards to protect patient access to the treatment options they need.  The compromise bill also incorporates language, authored by Senator Mikulski, that ensures this information is disseminated in a manner that is understood by patients.  It expands patient safeguards, including a focus on clinical effectiveness research, not cost-effectiveness; and includes safeguards to ensure that the Centers for Medicare and Medicaid Services (CMS) will not misuse CER results in ways that overlook differences in patient needs or discriminate against the elderly or people with disabilities.

About PIPC
The Partnership to Improve Patient Care (PIPC) was formed in November 2008 to support new comparative effectiveness research proposals that are centered on patient and provider needs; raise awareness about the value of well-designed CER; and promote the important role of continued medical innovation as part of the solution to cost and quality challenges in health care. PIPC members include a wide range of healthcare organizations representing patient, provider and industry advocacy groups.